Captrust Financial Advisors Cyto Dyn Inc. Call Options Transaction History
Captrust Financial Advisors
- $38.8 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CYDY
# of Institutions
11Shares Held
278KCall Options Held
0Put Options Held
0-
Diversified Trust CO45.8KShares$15,1100.0% of portfolio
-
Williams Jones Wealth Management, Llc. New York, NY45KShares$14,8500.0% of portfolio
-
Virtue Capital Management, LLC Brentwood, TN45KShares$14,8500.0% of portfolio
-
Rfp Financial Group LLC Atlanta, GA41.5KShares$13,6780.0% of portfolio
-
Next Capital Management LLC32.5KShares$10,7250.0% of portfolio
About CytoDyn Inc.
- Ticker CYDY
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 813,040,000
- Market Cap $268M
- Description
- CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...